Sodium–glucose cotransporter 2 inhibitors in horses—Magic bullet or latest fad?
Equine Veterinary Journal · 2023
DOI: 10.1111/evj.13944 ↗Kurz gefasst
Editorial in der Zeitschrift Equine Veterinary Journal, 2023. Verfasst von Tania Sundra und 3 weiteren Autor:innen. Beteiligte Einrichtung: Avon Ridge Equine Veterinary Services, Brigadoon, Western Australia, Australia. Hauptthemen laut MEDLINE: Hyperinsulinism, Insulin Resistance, Horse Diseases, Foot Diseases. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 52 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Avon Ridge Equine Veterinary Services, Brigadoon, Western Australia, Australia.
- Equiimed, Perth, Western Australia, Australia.
- School of Veterinary and Biomedical Sciences, Murdoch University, Murdoch, Western Australia, Australia.
- EMT Consulting, Tiverton, Devon, UK.
ORCID-Profile: Tania Sundra, Guy Lester, Gabriele Rossi, David Rendle
Zitieren
APA
Sundra, T., Lester, G., Rossi, G., & Rendle, D. (2023). Sodium–glucose cotransporter 2 inhibitors in horses—Magic bullet or latest fad?. Equine Veterinary Journal. https://doi.org/10.1111/evj.13944
Vancouver
Sundra T, Lester G, Rossi G, Rendle D. Sodium–glucose cotransporter 2 inhibitors in horses—Magic bullet or latest fad?. Equine Veterinary Journal. 2023. doi:10.1111/evj.13944
BibTeX
@article{Sundra2023,
author = {Sundra, Tania and Lester, Guy and Rossi, Gabriele and Rendle, David},
title = {Sodium–glucose cotransporter 2 inhibitors in horses—Magic bullet or latest fad?},
journal = {Equine Veterinary Journal},
year = {2023},
doi = {10.1111/evj.13944}
}
EUVIMED